Chitosan Nanoparticles for the Linear Release of Model Cationic Peptide
Author(s) -
Anna Maria Piras,
Stefania Sandreschi,
Giuseppantonio Maisetta,
Semih Esin,
Giovanna Batoni,
Emo Chiellini
Publication year - 2015
Publication title -
pharmaceutical research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.815
H-Index - 206
eISSN - 1573-904X
pISSN - 0724-8741
DOI - 10.1007/s11095-014-1615-9
Subject(s) - chitosan , cationic polymerization , drug delivery , chemistry , active ingredient , peptide , nanoparticle , controlled release , combinatorial chemistry , biophysics , nanotechnology , chemical engineering , materials science , biochemistry , organic chemistry , pharmacology , medicine , engineering , biology
The present study is focused on the development of a model drug delivery system (DDS) based on Chitosan (CS) nanoparticles using Renin substrate I (RSI) as model agent. RSI shares the main chemical-physical features of several biologically active antimicrobial peptides (AMPs). AMPs have a great therapeutic potential that is hampered by their lability in the biological fluids and as such they are perfect candidates for DDS. The development studies of quality DDS loaded with AMPs would require highly sensitive and specific quantification assays. The use of RSI allowed for the fine-tuning and optimization of the formulation parameters to promote the hydrophobic interactions between CS and the cationic peptide, favour the loading of the active ingredient and enhance the release properties of the carrier.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom